Cross-cultural adaptation of the CRS-PRO questionnaire into French - Archive ouverte HAL Access content directly
Journal Articles Journal of Otolaryngology - Head and Neck Surgery Year : 2023

Cross-cultural adaptation of the CRS-PRO questionnaire into French

Abstract

Abstract Background Chronic rhinosinusitis (CRS), encompasses many different clinical patterns with variable response to treatment. Precise criteria specifying disease severity and control are lacking in the current literature. Our aim was to perform a cross-cultural adaptation of the CRS-PRO, creating a French version for use as a routine questionnaire in the assessment of patients with CRS. Methods The CRS-PRO questionnaire was translated according to the recommendations of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) through a three-step procedure including a backward translation. Results Seven of 12 items were initially discordant between the three translators before achieving consensus (Step 1). Two of 12 items were discordant between the backward translation and the initial CRS-PRO version regarding the word “mucus”(Step 2). Step 3 allowed the creation of a French proof-read version of the CRS-PRO questionnaire. Thirty patients were included for initial validation, mean age of 49.2 ± 15 years and 63.3% (19/30) male. It took them 67 ± 23 s to complete the questionnaire without any patients requiring more than 2 min. Conclusion This study presents the French version of the CRS-PRO questionnaire—an adapted, validated, and well-accepted instrument to evaluate the CRS symptoms in the French speaking population.

Dates and versions

hal-04384204 , version 1 (10-01-2024)

Identifiers

Cite

Maxime Fieux, Florent Carsuzaa, Jeremy Charriot, Justin Michel, Fabien Subtil, et al.. Cross-cultural adaptation of the CRS-PRO questionnaire into French. Journal of Otolaryngology - Head and Neck Surgery, 2023, 52 (1), pp.77. ⟨10.1186/s40463-023-00683-0⟩. ⟨hal-04384204⟩
16 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More